Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Cesarman-Maus

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society|July 17, 2003
The consular Program for Mexican Communities Abroad: a source of outreach for health workersGabriela Cesarman-Maus
British Journal of Haematology|April 22, 2005
Molecular mechanisms of fibrinolysisGabriela Cesarman-Maus, Katherine A Hajjar
Hematology (Amsterdam, Netherlands)|April 18, 2012
Thrombosis in multiple myeloma (MM)Gabriela Cesarman-Maus, Esteban Braggio, Rafael Fonseca
Current Drug Metabolism|April 18, 2017
News in the Indications of Direct Oral Anticoagulants According to the American College of Chest Physicians 2016 GuidelinesGabriela Cesarman-Maus, Guillermo J Ruiz-Argüelles
Cancers|October 31, 2018
Oncolytic Viruses for Canine Cancer TreatmentDiana Sánchez, Gabriela Cesarman-Maus, Alfredo Amador-Molina, et al.
Thrombosis Research|February 5, 2014
Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell originGabriela Cesarman-Maus, Esteban Braggio, Carmen Lome-Maldonado, et al.
AIDS Research and Therapy|June 1, 2017
Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcomaPatricia Volkow, Gabriela Cesarman-Maus, Pamela Garciadiego-Fossas, et al.
Research and Practice in Thrombosis and Haemostasis|November 18, 2024
Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scoresOmar Eduardo Fernandez-Vargas, Isabel Amezcua, Beatriz Cabello, et al.
Ejhaem|June 10, 2026
Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa StudyK Alexandra Sanchez, Gabriela Cesarman-Maus, Michelle Flores-Cruz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 28, 2022
Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative CareSilvia Rosa Allende-Pérez, Gabriela Cesarman-Maus, Adriana Peña-Nieves, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society|July 17, 2003
The consular Program for Mexican Communities Abroad: a source of outreach for health workersGabriela Cesarman-Maus
British Journal of Haematology|April 22, 2005
Molecular mechanisms of fibrinolysisGabriela Cesarman-Maus, Katherine A Hajjar
Hematology (Amsterdam, Netherlands)|April 18, 2012
Thrombosis in multiple myeloma (MM)Gabriela Cesarman-Maus, Esteban Braggio, Rafael Fonseca
Current Drug Metabolism|April 18, 2017
News in the Indications of Direct Oral Anticoagulants According to the American College of Chest Physicians 2016 GuidelinesGabriela Cesarman-Maus, Guillermo J Ruiz-Argüelles
Cancers|October 31, 2018
Oncolytic Viruses for Canine Cancer TreatmentDiana Sánchez, Gabriela Cesarman-Maus, Alfredo Amador-Molina, et al.
Thrombosis Research|February 5, 2014
Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell originGabriela Cesarman-Maus, Esteban Braggio, Carmen Lome-Maldonado, et al.
AIDS Research and Therapy|June 1, 2017
Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcomaPatricia Volkow, Gabriela Cesarman-Maus, Pamela Garciadiego-Fossas, et al.
Research and Practice in Thrombosis and Haemostasis|November 18, 2024
Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scoresOmar Eduardo Fernandez-Vargas, Isabel Amezcua, Beatriz Cabello, et al.
Ejhaem|June 10, 2026
Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa StudyK Alexandra Sanchez, Gabriela Cesarman-Maus, Michelle Flores-Cruz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 28, 2022
Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative CareSilvia Rosa Allende-Pérez, Gabriela Cesarman-Maus, Adriana Peña-Nieves, et al.
Pageof 4